SION Sionna Therapeutics, Inc. Net Assets per Single Share

Official company branding of Sionna Therapeutics Inc (SION)

Laboratory centers and contract manufacturing facilities for DNA-based drugs operate on a continuous schedule, modernizing their infrastructure to increase production volumes. This price chart on GURU.Markets with the 5.92 metric illustrates the dynamics of Sionna Therapeutics Inc (SION), whose operations rely on the fight against cystic fibrosis and patent law, ignoring inflation. Such research is completely autonomous from macroeconomic shifts, demonstrating exceptional immunity to market turmoil.

SION (Sionna Pharma) Equity per Share history from 02/08/2025 to 10/29/2026

Summary analytical data breakdowns for sionnatx.com (SION)

- current quotes and average value forecast:
Price Chart Sionna Pharma|SION - Average Forecast Price
- market capitalization data:
Market Value Sionna Therapeutics Inc|SION - Business Value
- shareholders' equity book value data:
Book Value per Share Sionna Therapeutics|SION - Accounting Capitalization|Market Value to Book Value Ratio sionnatx.com|SION - Total Business Assets
- debt burden and liquidity indicators:
Total Debt to Capital Sionna Therapeutics Inc|SION - Long-Term Debt to Capital|Short-Term Debt to Equity Sionna Therapeutics|SION - Company Total Debt Obligations|Debts to Book Capitalization Sionna Therapeutics Inc|SION - Long-Term Debt Volume|Company Short-Term Debt Sionna Therapeutics
Fundamental company analysis:Sionna Pharma (SION)
Manufactured products of Sionna Therapeutics

Book value per share reflects the size of the company's net assets minus all liabilities, allocated per security. For Sionna Therapeutics Inc (SION), this metric demonstrates the capitalization of resources directed toward the creation of pathogenetic therapy for cystic fibrosis. By analyzing book value per share data, an investor assesses the real material base of the business. Growth in this metric confirms the effectiveness of investments in innovative developments. Stable dynamics of this indicator guarantee the fundamental stability of the issuer.

Competitors of Sionna Therapeutics Inc

TEM - Net Assets per Single Share|Net Asset Value per Share Qiagen Corp|Ionis Pharmaceuticals (IONS) - Net Assets per Single Share|Equity per Share RGEN|RNA (Avidity Biosciences, Inc.) - Book Value per Share|Equity per Share CRSP (CRISPR Therapeutics Inc)|Net Assets per Single Share Sema4 (WGS)|Ultragenyx Corp - Equity per Share|Book Value per Share BEAM (Beam Therapeutics Inc.)|Book Value per Share sarepta.com SRPT|TWST - Net Assets per Single Share|Net Assets per Share 10x Genomics Inc TXG|NTLA: Book Value per Share|STOK - Net Assets per Share|Net Assets per Single Share BioLife Solutions, Inc.|Net Asset Value per Share wavelifesciences.com WVE|Net Assets per Single Share Maze Therapeutics (MAZE)|Prime Medicine Inc - Equity per Share|Net Assets per Single Share Taysha TSHA|QURE: Equity per Share|MeiraGTx Holdings plc - Book Value per Share|RGNX - Book Value per Share|SLDB (Solid Biosciences) - Accounting Value per Share|Ocugen Inc - Accounting Value of a Share|Accounting Value per Share PACB|BNTC (Benitec Corp) - Book Price of a Share|Book Value per Share DSGN|RCKT (rocketpharma.com) - Accounting Value of a Share|Book Value per Share FDMT (4D Molecular Therapeutics, Inc.)|Lexeo Therapeutics Inc. (LXEO) - Net Asset Value per Share|KRRO - Net Assets per Single Share|Accounting Value of a Share EDIT (Editas Corp)|SLN: Book Value per Share|ProQR Therapeutics (PRQR) - Book Value per Share|Net Assets per Single Share Codexis Inc|Sangamo Therapeutics Inc. - Share Book Value|Book Value per Share NAUT|MGX - Net Asset Value per Share|Precision BioSciences, Inc. - Accounting Value per Share|Book Value per Share Generation Bio Co GBIO|BOLD: Accounting Value per Share|Exicure, Inc. - Book Price of a Share|IMNN: Book Value per Share|PHIO - Net Assets per Share|MBIO (Mustang Bio Inc) - Book Value per Share|Accounting Value per Share TransCode (RNAZ)|Net Assets per Single Share Bionano Genomics, Inc. (BNGO)|Net Assets per Share Applied DNA Sciences Inc|Bluebird Bio - Accounting Value per Share|Accounting Value of a Share IPA|Omega Therapeutics - Book Value per Share|Net Assets per Share singulargenomics.com OMIC|Regulus Therapeutics Inc. (RGLS) - Net Assets per Single Share|Equity per Share SYRS|TBIO (Codex DNA) - Book Value per Share|Accounting Value per Share TRACON Pharmaceuticals, Inc (TCON)|Net Assets per Single Share Unity Biotechnology (UBX)